Rocket Pharmaceuticals, Inc. (RCKT)

Rocket Pharmaceuticals Statistics

Total Valuation

RCKT has a market cap or net worth of $534.16 million. The enterprise value is $372.82 million.

Market Cap	534.16M
Enterprise Value	372.82M

Important Dates

The last earnings date was Thursday, February 26, 2026, after market close.

Earnings Date	Feb 26, 2026
Ex-Dividend Date	n/a

Share Statistics

RCKT has 108.57 million shares outstanding. The number of shares has increased by 17.21% in one year.

Current Share Class	108.57M
Shares Outstanding	108.57M
Shares Change (YoY)	+17.21%
Shares Change (QoQ)	+0.19%
Owned by Insiders (%)	3.51%
Owned by Institutions (%)	69.19%
Float	86.97M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	1.94
P/TBV Ratio	2.52
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 6.38, with a Debt / Equity ratio of 0.09.

Current Ratio	6.38
Quick Ratio	6.25
Debt / Equity	0.09
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-120.84

Financial Efficiency

Return on equity (ROE) is -60.27% and return on invested capital (ROIC) is -36.12%.

Return on Equity (ROE)	-60.27%
Return on Assets (ROA)	-33.29%
Return on Invested Capital (ROIC)	-36.12%
Return on Capital Employed (ROCE)	-76.11%
Weighted Average Cost of Capital (WACC)	6.68%
Revenue Per Employee	n/a
Profits Per Employee	-$1.10M
Employee Count	202
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -40.07% in the last 52 weeks. The beta is 0.45, so RCKT's price volatility has been lower than the market average.

Beta (5Y)	0.45
52-Week Price Change	-40.07%
50-Day Moving Average	3.87
200-Day Moving Average	3.37
Relative Strength Index (RSI)	62.84
Average Volume (20 Days)	3,150,862

Short Selling Information

The latest short interest is 13.99 million, so 12.88% of the outstanding shares have been sold short.

Short Interest	13.99M
Short Previous Month	14.46M
Short % of Shares Out	12.88%
Short % of Float	16.08%
Short Ratio (days to cover)	6.83

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-228.52M
Pretax Income	-223.12M
Net Income	-223.12M
EBITDA	-217.49M
EBIT	-228.52M
Earnings Per Share (EPS)	-$2.01

Balance Sheet

The company has $188.93 million in cash and $24.88 million in debt, with a net cash position of $164.05 million or $1.51 per share.

Cash & Cash Equivalents	188.93M
Total Debt	24.88M
Net Cash	164.05M
Net Cash Per Share	$1.51
Equity (Book Value)	277.22M
Book Value Per Share	2.56
Working Capital	162.53M

Cash Flow

In the last 12 months, operating cash flow was -$190.01 million and capital expenditures -$440,000, giving a free cash flow of -$190.45 million.

Operating Cash Flow	-190.01M
Capital Expenditures	-440,000
Free Cash Flow	-190.45M
FCF Per Share	-$1.75

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

RCKT does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-17.21%
Shareholder Yield	-17.21%
Earnings Yield	-41.56%
FCF Yield	-35.47%

Analyst Forecast

The average price target for RCKT is $29.65, which is 502.64% higher than the current price. The consensus rating is "Buy".

Price Target	$29.65
Price Target Difference	502.64%
Analyst Consensus	Buy
Analyst Count	14
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	-53.56%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	1